How Much Can In-Vitro Diagnostic Substance Manufacturing Businesses Get in SBA Loans?
25 SBA loans totaling $10.2M have been approved for in-vitro diagnostic substance manufacturing businesses (NAICS 325413). The average approved SBA loan is $408K, which is 20% above avg the $340K national average. 20 active lenders fund this industry.
NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing) received 25 SBA loans worth $10.2M across 5+ states. Average loan $408K, average term 128 months.20 active SBA approved lenders fund this industry.Manufacturers in NAICS 31 to 33 qualify for FY2027 SBA fee terms and can access the MARC revolving credit program.
Is SBA Lending Growing for In-Vitro Diagnostic Substance Manufacturing?
FY2027 Manufacturing Fee Waivers Active
The SBA has waived both 504 fees for manufacturers in NAICS 31 to 33 through September 30, 2027:
504 loans: all guaranty fees waived for manufacturing
7(a) loans of $700,000 or less: 0% upfront fee for manufacturers
Revolving credit line: manufacturers only, launched Oct 2025
The proposed Made in America Manufacturing Finance Act (H.R. 3174) would double SBA limits to $10M for domestic manufacturers, currently passed House, awaiting Senate vote.
Which SBA Program Do In-Vitro Diagnostic Substance Manufacturing Businesses Use Most?
What Is the Best SBA Loan for In-Vitro Diagnostic Substance Manufacturing?
Popular for manufacturing equipment and real estate, with 504 fees waived in FY2027
Where Are In-Vitro Diagnostic Substance Manufacturing SBA Loans Most Common?
SBA Lending Activity in In-Vitro Diagnostic Substance Manufacturing
20 SBA lenders have funded 25 loans to in-vitro diagnostic substance manufacturing businesses (NAICS 325413). Which lender approves your deal depends on your location, loan size, credit profile and time in business, not on who funded someone else. PeerSense makes the introduction.
In-Vitro Diagnostic Substance Manufacturing Industry Context
Talk to PeerSense
PeerSense sources capital for in-vitro diagnostic substance manufacturing businesses. The capital source sets the terms. No upfront fee. Talk to PeerSense. Referral fee at closing.
Retainers
Down with SBA 7(a)
Terms Available
Talk to PeerSense about financing a In-Vitro Diagnostic Substance Manufacturing business.
Tell us your loan amount and use of funds. PeerSense sources capital. The capital source sets the terms.
SBA 7(a) / 504: PeerSense will reach out. No obligation.
How Does SBA Lending Work for In-Vitro Diagnostic Substance Manufacturing Businesses?
Across all SBA loan programs, 25 loans have been approved for businesses classified under NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing), representing $10.2M in total capital deployed. The average approved loan of $408K is 20% above avg the national SBA average of $340K, with typical repayment terms of 128 months.
SBA lending for in-vitro diagnostic substance manufacturing has remained relatively stable across recent fiscal years. 20 active lenders continue funding this sector, providing consistent access to capital for both new ventures and established businesses looking to expand.
Notably, 24% of SBA loans in this industry use the 504 program (well above the national average), indicating that in-vitro diagnostic substance manufacturing businesses frequently finance major fixed assets like real estate, heavy equipment, or facility buildouts. The 504 program offers up to $5.5M with below market fixed rates and only 10% down from the borrower.
As a manufacturing business under NAICS 31 to 33, you qualify for FY2027 SBA fee terms through September 30, 2027. For manufacturers, the SBA has waived the 504 upfront guaranty fee and annual service fee, and the 7(a) upfront fee is 0% on loans of $700,000 or less. Additionally, the MARC (Manufacturers' Access to Revolving Credit) program launched in October 2025, offering up to $5M in revolving credit exclusively for domestic manufacturers, a first for SBA lending.
Frequently Asked Questions: In-Vitro Diagnostic Substance Manufacturing SBA Loans
What is the average SBA loan size for in-vitro diagnostic substance manufacturing businesses?
Which SBA loan program is best for a in-vitro diagnostic substance manufacturing business?
How many lenders fund SBA loans for in-vitro diagnostic substance manufacturing?
Are there SBA fee waivers for manufacturing businesses in 2026?
How does PeerSense help in-vitro diagnostic substance manufacturing businesses get SBA loans?
Related Manufacturing Industries
Commercial Gravure Printing
Commercial Lithographic Printing
Commercial Screen Printing
All Other Plastics Product Manufacturing
Other Commercial Printing
Cut Stone and Stone Product Manufacturing
Data aggregated from SBA loan records (1992 to 2025). In-Vitro Diagnostic Substance Manufacturing defined by NAICS code 325413. Not financial advice. PeerSense sources capital through a curated network of commercial lenders and capital sources. Consult a lending professional before making financial decisions.